SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
ModeX Therapeutics, An OPKO Health Company
LTZ Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Eli Lilly and Company
GenomeFrontier Therapeutics TW Co., Ltd.
Ipsen
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Ipsen
Cyteir Therapeutics, Inc.
Atara Biotherapeutics
Gilead Sciences
Novartis
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
SymBio Pharmaceuticals
Novartis